Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia
Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia have?
Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia has 306 citations in the OpenAlex counts ScholarIQ stores.
When was Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia published?
Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia has 2019 year in the ScholarIQ index.
What is the open-access status of Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia?
Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia has bronze oa status in the ScholarIQ index.
What is the DOI of Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia?
The DOI for Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia is on the source record.
What is the PMID of Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia?
The PMID for Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia is on the source record.
What is the OpenAlex record for Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia?
The OpenAlex for Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia is on the source record.